Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Abcam Ltd ABCZF

Healthcare Biotechnology
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:ABCZF)

Abcam Announces Review of Strategic Alternatives

PR Newswire June 23, 2023

ABCAM PLC Result of Annual General Meeting

PR Newswire May 17, 2023

ABCAM PLC: Upcoming Abcam Investor Events

PR Newswire April 17, 2023

Abcam to Report Full Year Results on Monday, March 20, 2023

PR Newswire March 10, 2023

Abcam plc: Update on AIM Delisting

PR Newswire December 12, 2022

ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting

PR Newswire November 11, 2022

Abcam: Appointment of Vice President of Investor Relations

PR Newswire June 27, 2022

Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients

PR Newswire June 22, 2021

A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need

Canada NewsWire November 13, 2018
View More News ››

Opinion & Analysis (GREY:ABCZF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:ABCZF)

Apoptosis Assay Market Trends, Demand, Share & Size 2022-27

According to IMARC Group’s latest report, titled “Apoptosis Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and...
edwardebreen15 - August 18, 2022

News Release

newcoin - June 23, 2021

test

https://tse1.mm.bing.net/th?id=OIP.86QzA8QPRafB4ZfDmbAuuAHaFj&w=282&h=204&c=7&qlt=90&o=4&dpr=1.25&pid=1.7
theslip - December 18, 2017
View more Bullboard ››

Revive Therapeutics Ltd

Revive Therapeutics Ltd

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »